Skip to content

APRE

Aprea Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.79
−1.49%
Ask drillr
  • Aug 12, 2026, 12:30 UTC

    Aprea Therapeutics announced its financial results for the second quarter of 2026.